INDUCTION OF INFLAMMATORY CYTOKINE RELEASE FROM CULTURED HUMAN MONOCYTES BY C-REACTIVE PROTEIN

被引:284
|
作者
BALLOU, SP [1 ]
LOZANSKI, G [1 ]
机构
[1] MED ACAD POZNAN, INST OBSTET & GYNECOL, POZNAN, POLAND
关键词
INTERLEUKIN-1; INTERLEUKIN-6; TUMOR NECROSIS FACTOR; INFLAMMATION; ACUTE PHASE RESPONSE;
D O I
10.1016/1043-4666(92)90079-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human acute phase protein, C-reactive protein (CRP), is capable of specifically binding to and modulating the function of mononuclear phagocytes. To investigate whether CRP can also affect the capacity of these cells to produce inflammatory cytokines, enzyme immunoassays and Western blot techniques were used to quantitate interleukin 1β (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) produced by freshly-isolated normal human monocytes. CRP induced the rapid release of each cytokine, with significantly elevated levels in culture supernatants at 4 hours and maximal levels of TNF-α at 8 hours, and of IL-1β and IL-6 at 16 hours of culture. The effects of CRP were dose-dependent; greater than 10-fold increases of each cytokine were observed following culture with greater than or equal to 50 μg/ml CRP, concentrations which are often found in the presence of moderate to severe inflammation or tissue injury. The induction of cytokine release by CRP was unaffected by inclusion of 25 μg/ml polymyxin-B in culture media, but was completely abrogated by prior boiling of the CRP, a procedure which had no effect on induction of monocyte cytokine release by lipopolysaccaride. The dose-dependent induction of inflammatory cytokines by CRP provides further support for the hypothesis that interaction with mononuclear phagocytes constitutes an important biological role for this acute phase protein. © 1992.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [1] C-REACTIVE PROTEIN (CRP) INDUCES CYTOKINE PRODUCTION BY MONOCYTES
    BALLOU, SP
    LOZANSKI, G
    FASEB JOURNAL, 1991, 5 (04): : A634 - A634
  • [2] INDUCTION OF CYTOKINE RELEASE FROM HUMAN MONOCYTES BY COXSACKIEVIRUS INFECTION
    HENKE, A
    NAIN, M
    STELZNER, A
    GEMSA, D
    EUROPEAN HEART JOURNAL, 1991, 12 : 134 - 136
  • [3] Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release
    Casals, C
    Arias-Díaz, J
    Valiño, F
    Sáenz, A
    García, C
    Balibrea, JL
    Vara, E
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 284 (03) : L466 - L472
  • [4] Procoagulant induction on human monocytes by proinflammatory stimulants is amplified by C-reactive protein and interferon-gamma
    Nakagomi, A
    Freedman, SB
    Lau, W
    Geczy, CL
    CIRCULATION, 1996, 94 (08) : 4063 - 4063
  • [5] Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide
    Li, JJ
    Chen, XJ
    CORONARY ARTERY DISEASE, 2003, 14 (04) : 329 - 334
  • [6] Inflammatory cytokine and C-reactive protein concentrations in dogs with systemic inflammatory response syndrome
    Gommeren, Kris
    Desmas, Isabelle
    Garcia, Alexandra
    Bauer, Natalie
    Moritz, Andreas
    Roth, Joachim
    Peeters, Dominique
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2018, 28 (01) : 9 - 19
  • [7] SPECIFIC BINDING OF HUMAN C-REACTIVE PROTEIN TO HUMAN-MONOCYTES INVITRO
    BALLOU, SP
    BUNIEL, J
    MACINTYRE, SS
    JOURNAL OF IMMUNOLOGY, 1989, 142 (08): : 2708 - 2713
  • [8] Release of C-reactive protein by stenting
    Tiong, AY
    Brieger, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1733 - 1734
  • [9] TUMORICIDAL ACTIVITY AND CYTOKINE SECRETION OF HUMAN MONOCYTES AND ALVEOLAR MACROPHAGES IS MODULATED BY A SYNTHETIC PEPTIDE OF C-REACTIVE PROTEIN (CRP)
    THOMASSEN, MJ
    ANTAL, J
    CONNORS, M
    WIEDEMANN, H
    MEEKER, D
    EPPSTEIN, D
    DEODHAR, S
    BARNA, B
    FASEB JOURNAL, 1992, 6 (04): : A1151 - A1151
  • [10] THE C-REACTIVE PROTEIN IN INFLAMMATORY RESPONSE
    LAURENT, P
    NOUVELLE PRESSE MEDICALE, 1981, 10 (34): : 2817 - 2820